Anixa Biosciences Inc’s recent filing unveils that its Director Titterton Lewis H jr acquired Company’s shares for reported $30800.0 on Jul 31 ’25. In the deal valued at $3.08 per share,10,000 shares were bought. As a result of this transaction, Titterton Lewis H jr now holds 953,334 shares worth roughly $3.36 million.
Then, KUMAR AMIT bought 5,000 shares, generating $15,800 in total proceeds. Upon buying the shares at $3.16, the Chief Executive Officer now owns 579,925 shares.
Before that, Baskies Arnold M bought 5,000 shares. Anixa Biosciences Inc shares valued at $16,950 were divested by the Director at a price of $3.39 per share. As a result of the transaction, Baskies Arnold M now holds 125,000 shares, worth roughly $0.44 million.
Maxim Group initiated its Anixa Biosciences Inc [ANIX] rating to a Buy in a research note published on March 21, 2025; the price target was $10. A number of analysts have revised their coverage, including Chardan Capital Markets’s analysts, who began to cover the stock in late December with a ‘”a Buy”‘ rating. H.C. Wainwright began covering ANIX with “Buy” recommendation on April 12, 2021.
Price Performance Review of ANIX
On Monday, Anixa Biosciences Inc [NASDAQ:ANIX] saw its stock jump 19.93% to $3.52. Over the last five days, the stock has gained 18.12%. Anixa Biosciences Inc shares have risen nearly 13.92% since the year began. Nevertheless, the stocks have risen 51.72% over the past one year.
How much short interest is there in Anixa Biosciences Inc?
A steep rise in short interest was recorded in Anixa Biosciences Inc stocks on 2025-08-29, dropping by 5401.0 shares to a total of 0.41 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 0.42 million shares. There was a decline of -1.32%, which implies that there is a negative sentiment for the stock.